Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Alcon AG Regulatory Filings 2021

May 4, 2021

810_ffr_2021-05-04_b53beeb4-eeba-4b0f-9f9b-a0bf6fe5f969.zip

Regulatory Filings

Open in viewer

Opens in your device viewer

6-K 1 a6ker-q12021.htm 6-K html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd" Document created using Wdesk Copyright 2021 Workiva Document

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549


FORM 6-K


REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE

SECURITIES EXCHANGE ACT OF 1934

May 4, 2021

Commission File Number: 001-31269


ALCON INC.

(Registrant Name)

Chemin de Blandonnet 8 1214 Vernier, Geneva, Switzerland

(Address of principal executive office)


Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20‑F or Form 40-F: Form 20-F x Form 40-F

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):

EXHIBIT INDEX

Exhibit Number Description
99.1 Press release issued by Alcon Inc. dated May 4, 2021 titled “Alcon Reports First Quarter 2021 Results”
99.2 Alcon Inc. Interim Financial Report

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

Date: May 4, 2021 ALCON INC. — By: /s/ Timothy C. Stonesifer
Name: Timothy C. Stonesifer
Title: Authorized Representative
Date: May 4, 2021 By: /s/ Royce Bedward
Name: Royce Bedward
Title: Authorized Representative